GOLDMAN SACHS GROUP INC - PRONAI THERAPEUTICS INC ownership

PRONAI THERAPEUTICS INC's ticker is DNAI and the CUSIP is 74346L101. A total of 38 filers reported holding PRONAI THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PRONAI THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$59,000
+195.0%
39,901
+263.3%
0.00%
Q3 2016$20,000
-93.2%
10,982
-74.9%
0.00%
Q1 2016$295,000
-1.3%
43,757
+119.8%
0.00%
Q4 2015$299,000
-15.5%
19,905
+15.3%
0.00%
Q3 2015$354,00017,2610.00%
Other shareholders
PRONAI THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Hayman Capital 422,200$8,664,0004.00%
ADAMS STREET PARTNERS LLC 1,159,546$17,845,0003.79%
RA Capital Management 604,982$12,414,0001.78%
VHCP Management, LLC 250,000$5,130,0001.32%
CAXTON CORP 45,719$938,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,348,401$27,669,0001.07%
SECTORAL ASSET MANAGEMENT INC 862,766$17,290,0000.79%
Orbimed Advisors 1,989,949$40,834,0000.41%
Cormorant Asset Management, LP 53,153$1,091,0000.17%
DAFNA Capital Management LLC 8,500$174,0000.17%
View complete list of PRONAI THERAPEUTICS INC shareholders